文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

为什么我们不建议给幼儿接种流感疫苗?对澳大利亚家长和初级保健提供者的定性研究

Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers.
PubMed 文献 · Vaccine · 2018-01-05

该研究采用横断面定性设计,于2014年6月至2015年7月在澳大利亚墨尔本对初级保健提供者进行30次深度访谈,并开展5场家长焦点小组(n=50),探讨家长和初级保健提供者对5岁以下儿童流感疫苗接种的观点与态度。结果显示家长担心疫苗可致流感且认为儿童需建立自身免疫力,初级保健提供者则关注疫苗效力、自付费用及健康儿童流感疾病负担的不确定性。

要点

  • 家长认为疫苗可能引起流感且儿童需建立自身免疫力,故接种非必要。
  • 家长表示若全科医生推荐且流感疫苗纳入免疫规划则会考虑接种。
  • 初级保健提供者关注疫苗效力、家庭自付费用及健康儿童流感疾病负担的不确定性。

核心结论

  • 尽管流感疫苗安全性已确立,但接种障碍包括对疫苗接种医源性效应的担忧、接种程序安排及对流感严重性的认知。
  • 更新流感及疫苗效力信息并将流感疫苗接种纳入免疫规划可能克服部分障碍,以提高该脆弱人群的流感疫苗接种率。

研究设计与样本

  • 横断面定性研究,于2014年6月至2015年7月在澳大利亚墨尔本对初级保健提供者(全科医生、执业护士、母婴健康护士和药剂师)进行30次深度访谈,并对家长开展5场焦点小组(n=50)。
  • 数据采用主题分析法分析。

主要发现

  • 家长认为疫苗可能引起流感,且儿童需要建立自身免疫力,故流感疫苗接种对其子女不必要。
  • 家长表示若全科医生推荐且流感疫苗纳入免疫规划,他们会考虑为子女接种。
  • 初级保健提供者亦对疫苗效力及家庭自付费用表示担忧,并对健康儿童流感死亡率与发病率存在不确定性。
  • 初级保健提供者表示会向高危人群(如患有慢性疾病和哮喘的儿童)推荐疫苗。

临床怎么用

  • 作者认为,更新流感及疫苗效力信息并将流感疫苗接种纳入免疫规划,可能克服部分接种障碍,以提高该脆弱人群的流感疫苗接种率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Influenza vaccination has been shown to be safe and effective against influenza and in the prevention of complicating secondary respiratory illnesses. However, its uptake in young children remains low. This study explored the views, attitudes and practices of parents and primary care providers (PCPs) on their knowledge and acceptance of influenza vaccination in children under 5. METHODS: Using a cross-sectional qualitative research design, we conducted 30 in-depth interviews with PCPs (i.e., general practitioners, practice nurses, maternal and child health nurses, and pharmacists) and five focus groups with parents (n = 50) between June 2014 and July 2015 in Melbourne, Australia. Data were thematically analysed. RESULTS: Parents thought the vaccine could cause influenza, and influenza vaccination was not necessary for their children as they needed to build their own 'immunity'. Parents said that they would consider vaccinating their children if recommended by their GP and if the influenza vaccine was part of the immunisation schedule. PCPs also expressed concerns regarding the efficacy of the vaccine as well as out-of-pocket costs incurred by families, and uncertainty regarding the mortality and morbidity of influenza in otherwise healthy children. However, they said they would recommend the vaccine to high-risk groups (e.g. children with chronic disease(s), and asthma). CONCLUSION: Despite the established safety of influenza vaccines, barriers to uptake include concerns regarding the iatrogenic effects of vaccination, its administration schedule, and knowledge of influenza severity. Updated information on influenza and the efficacy of the vaccine, and incorporating influenza vaccination into the immunisation schedule may overcome some of these barriers to increase influenza vaccination in this vulnerable cohort.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Biezen R, Grando D, Mazza D, et al. Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers. Vaccine. 2018. PMID: 29310901. doi:10.1016/j.vaccine.2017.12.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。